Literature DB >> 2310436

Brain death in infants: sensitivity and specificity of current criteria.

M H Kohrman1, B S Spivack.   

Abstract

Guidelines for the determination of brain death in children were recently published by a multidisciplinary task force. We report a 3-month-old female who fulfilled these criteria but regained partial cortical and brainstem function for a prolonged period. This patient and similar newborn patients are analyzed with respect to sensitivity and specificity of the suggested criteria. Caution is recommended in assuming irreversibility of absent cerebral function in young infants, even beyond the neonatal period.

Entities:  

Mesh:

Year:  1990        PMID: 2310436     DOI: 10.1016/0887-8994(90)90078-f

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

1.  Establishing brain death: the potential role of nuclear medicine in the search for a reliable confirmatory test.

Authors:  M S George
Journal:  Eur J Nucl Med       Date:  1991

2.  Declaring pediatric brain death: current practice in a Canadian pediatric critical care unit.

Authors:  B L Parker; T C Frewen; S D Levin; D A Ramsay; G B Young; R H Reid; N C Singh; J M Gillett
Journal:  CMAJ       Date:  1995-10-01       Impact factor: 8.262

3.  Brain tissue oxygenation in children diagnosed with brain death.

Authors:  Anthony A Figaji; Samuel J Kent
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

4.  Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime.

Authors:  D C Costa; I M Motteux; A C McCready
Journal:  Eur J Nucl Med       Date:  1991

5.  Is brain death diagnosis in newborns feasible?

Authors:  I Chatziioannidis; P Chouchou; N Nikolaidis
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

Review 6.  The intractable problems with brain death and possible solutions.

Authors:  Ari R Joffe; Gurpreet Khaira; Allan R de Caen
Journal:  Philos Ethics Humanit Med       Date:  2021-10-09       Impact factor: 2.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.